Maureen Lane

Maureen Lane

Company: Curis Inc.

Job title: Vice President, Clinical Science


Spliceosome Mutations as a Surrogate Biomarker for Emavusertib Treatment in MDS and AML 2:55 pm

• Spliceosome mutations have previously been characterized as prognostic biomarkers in heme malignancies • Specific splicesome mutations drive expression of the IRAK4-L isoform which is oncogenic • Emavusertib is an IRAK4 inhibitorRead more

day: Day 1 - PM - red

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.